title: Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesis.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Tager
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy / Q000201:enzymology* / Q000378:metabolism; D008246:Lysophospholipids / Q000096:biosynthesis* / Q000378:metabolism; D058990:Molecular Targeted Therapy; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D015398:Signal Transduction; D000099189:Lysophospholipase D
chemical_list: D008246:Lysophospholipids; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases; D000099189:Lysophospholipase D; C032881:lysophosphatidic acid